
STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy
A California biotech developing a combination therapy with the obesity drug Zepbound has raised a…

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a…

A growing body of data show that South Asians are at greater risk of developing…

STAT now publishes selected Letters to the Editor received in response to First Opinion essays…

What is the relationship between aging, memory loss, and overall cognition? That’s a matter of…

As former U.S. surgeons general, we call on the Biden administration to immediately finalize Food…

By some measures, private equity investment lagged in 2023, a year marked by growing distress…

Eventually, the luckiest companies get to deal with a very particular problem: what to do…

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve…
.jpg)
More than half of the injector-pen patents for several widely used diabetes treatments — including…

Sixteen billion dollars is a lot of money. But Monday’s announcement that the parent company…

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent…

Amgen is trying a unique strategy with its obesity drug candidate: testing whether it can…

Documents released this week shed new light on an aggressive strategy from vape maker Juul…

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a…

Happy Groundhog Day eve. Some takes and thoughts on Bluebird Bio’s quest for gene therapy…

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of…

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that…
.jpg)
A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company…

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are…

Senate Majority Leader Chuck Schumer (D-N.Y.) wants the federal government to investigate Zyn nicotine pouches….

The Dog Aging Project, which researchers say could yield promising leads for human longevity research,…

“People say it’s the closest thing to living without diabetes. They just feel so relieved…

Heart disease is the leading cause of death among women in the United States, and…

More than 60 million women in the United States have heart disease, and one of…

False-Positive Mammogram Result May be Warning of Later Breast Cancer Diagnosis Women who get a…

A third of adults over age 60 have occasional constipation, but being a woman of…

There are countless studies showing that physical activity helps improve mental and physical health, and…

Heel pain is one of the most pervasive foot complaints among older adults— not surprising…

You may have heard that chronic inflammation is associated with the development of serious diseases,…

My eyelids have been a bit droopy for years, but lately it’s getting worse and…

Cognitive stimulation—the kind associated with crossword puzzles, math games, and learning new hobbies—is a critical…

Cutting a Teaspoon of Salt Per Day Significantly Lowers Blood Pressure An antihypertensive medication is…

The human blood system is in a constant state of turnover. First-line immune defenders, like…

BOSTON — Doctors often don’t have a lot of time to chat with patients during…

For years, the playbook for many companies that wanted to market digital therapeutics was stupid…

I am getting bent out of shape over surgeons telling patients they cannot get a…

STAT now publishes selected Letters to the Editor received in response to First Opinion essays…

A preliminary evaluation by the Food and Drug Administration did not find evidence that GLP-1…

SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines…

New weight loss medications like Ozempic and Wegovy have garnered a lot of attention in…

Want to stay on top of the science and politics driving biotech today? Sign up to…

New artificial intelligence technologies made headlines last year for their ability to do everything from…

The supply of glucagon-like peptide-1 (GLP-1) receptor agonists is not expected to return to normal…

Novo Nordisk may already have one blockbuster obesity drug in its portfolio, but the Danish…

Margery Quackenbush was attending a board meeting of the nonprofit where she served as executive…

In a year of abortion restrictions, biotech industry upheaval, and revolutionary drug approvals, First Opinion…
.jpg)
There’s an old story in journalism, and it goes like this: A reporter is asked,…

About a decade ago, after becoming obese, Jacob Petersen lost weight so quickly that some…

Since spring 2022, a flood of migrants fleeing political instability in Venezuela — about 136,000…